MedTrace Logo

Lymph Drainage in Heart Failure

NCT05240638 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1

Last updated 2024-02-23

No results posted yet for this study

Summary

This study aims to test the safety and efficacy of lymph fluid drainage on heart congestion and shortness of breath symptoms among patients participants with heart failure.

Conditions

Interventions

DEVICE

TD Drainage

Image-guided percutaneous cannulation of the TD and drainage with an endovascular catheter (microcatheter)

Sponsors & Collaborators

Principal Investigators

  • Marat Fudim, MD · Duke University

Study Design

Allocation
NA
Purpose
DEVICE_FEASIBILITY
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-24
Primary Completion
2023-05-05
Completion
2023-07-07
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05240638 on ClinicalTrials.gov